Submitted by Anonymous (not verified) on 19 October 2026 - 12:05
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: Authorised